نتایج جستجو برای: vaccine efficacy

تعداد نتایج: 405191  

Journal: :The Lancet. Oncology 2012
Matti Lehtinen Jorma Paavonen Cosette M Wheeler Unnop Jaisamrarn Suzanne M Garland Xavier Castellsagué S Rachel Skinner Dan Apter Paulo Naud Jorge Salmerón Song-Nan Chow Henry Kitchener Júlio C Teixeira James Hedrick Genara Limson Anne Szarewski Barbara Romanowski Fred Y Aoki Tino F Schwarz Willy A J Poppe Newton S De Carvalho Maria Julieta V Germar Klaus Peters Adrian Mindel Philippe De Sutter F Xavier Bosch Marie-Pierre David Dominique Descamps Frank Struyf Gary Dubin

BACKGROUND Cervical intraepithelial neoplasia grade 2 or greater (CIN2+) is the surrogate endpoint used in licensure trials of human papillomavirus (HPV) vaccines. Vaccine efficacy against CIN3+, the immediate precursor to invasive cervical cancer, is more difficult to measure because of its lower incidence, but provides the most stringent evidence of potential cancer prevention. We report vacc...

2017
Jihyun Yang Sang-Mu Shim Thi Quyen Nguyen Eun-Ha Kim Kwang Kim Yong Taik Lim Moon-Hee Sung Richard Webby Haryoung Poo

In 2009, the global outbreak of an influenza pandemic emphasized the need for an effective vaccine adjuvant. In this study, we examined the efficacy of poly-γ-glutamic acid/chitosan (PC) nanogel as an adjuvant for the influenza vaccine. PC nanogel significantly enhanced antigen-specific cross-presentation and cytotoxic T lymphocyte (CTL) activity. Compared with alum, the protective efficacy of ...

Journal: :JAMA 1998
N Rosenstein O Levine J P Taylor D Evans B D Plikaytis J D Wenger B A Perkins

CONTEXT Use of the quadrivalent meningococcal vaccine for control of outbreaks has increased in recent years, but the efficacy of meningococcal vaccine during mass vaccination campaigns in US civilian populations has not been assessed. OBJECTIVES To evaluate the efficacy of the quadrivalent meningococcal vaccine against serogroup C meningococcal disease in a community outbreak setting and to ...

2013
Jodi K. Craigo Corin Ezzelarab Sheila J. Cook Liu Chong David Horohov Charles J. Issel Ronald C. Montelaro

Lentiviral envelope (Env) antigenic variation and associated immune evasion present major obstacles to vaccine development. The concept that Env is a critical determinant for vaccine efficacy is well accepted, however defined correlates of protection associated with Env variation have yet to be determined. We reported an attenuated equine infectious anemia virus (EIAV) vaccine study that direct...

Journal: :Jornal de pediatria 2006
Mauricio L Barreto Susan M Pereira Arlan A Ferreira

OBJECTIVES To review the protective efficacy of the first and second doses of BCG vaccine and to assess its major indications and contraindications. SOURCES OF DATA A systematic review of the literature was made by searching PubMed and selecting studies carried out in the last 50 years. The studies were grouped according to their design (clinical trials, case-control studies, and meta-analyse...

2016
Yi Cheng Dongbei Sheng Xiangdong Li Sumei Hong Lixia Guo Shasha Zhao Yue Yuan Jingjing Xue Hui Tian Yipin Ren Wujie Liu Kegong Tian

Background: Newcastle disease virus (NDV) genotype VII has become the dominant genotype in China. However, NDV genotype II was used to make current commercial NDV vaccines. The mismatch of genotypes between circulating and vaccine strains of viruses may compromise the efficacy of vaccines. Methods: In this study, a current circulating NDV was attenuated by mutations of multiple basic amino acid...

Journal: :Vaccine 2006
Katherine Goodwin Cécile Viboud Lone Simonsen

We performed a quantitative review of 31 vaccine antibody response studies conducted from 1986 to 2002 and compared antibody responses to influenza vaccine in groups of elderly versus younger adults. We did a weighted analysis of the probability of vaccine response (measured as seroconversion and seroprotection) for each vaccine component (H1, H3 and B antigens). Using a multiple regression mod...

2012
U. K. GRIFFITHS A. CLARK B. GESSNER A. MINERS C. SANDERSON E. R. SEDYANINGSIH K. E. MULHOLLAND

Global coverage of infant Haemophilus influenzae type b (Hib) vaccination has increased considerably during the past decade, partly due to GAVI Alliance donations of the vaccine to low-income countries. In settings where large numbers of children receive only one or two vaccine doses rather than the recommended three doses, dose-specific efficacy estimates are needed to predict impact. The obje...

A. Khorasani H. Keyvanfar H. Mahravani H. Soleimanjahi O. Madadgar,

Foot-and-mouth disease is an important viral disease of cloven-hoofed animals. Inactivated whole particle virus vaccines are still widely used in prophylactic vaccination campaigns. The choice of adjuvant is a very important factor in enhancing immune responses and the efficacy of inactivated vaccines. Montanide ISA 61 VG is a new ready-to-use mineral oil-based adjuvant developed by SEPPIC Inc....

Journal: :The New England journal of medicine 2013
Scott M Hammer Magdalena E Sobieszczyk Holly Janes Shelly T Karuna Mark J Mulligan Doug Grove Beryl A Koblin Susan P Buchbinder Michael C Keefer Georgia D Tomaras Nicole Frahm John Hural Chuka Anude Barney S Graham Mary E Enama Elizabeth Adams Edwin DeJesus Richard M Novak Ian Frank Carter Bentley Shelly Ramirez Rong Fu Richard A Koup John R Mascola Gary J Nabel David C Montefiori James Kublin M Juliana McElrath Lawrence Corey Peter B Gilbert

BACKGROUND A safe and effective vaccine for the prevention of human immunodeficiency virus type 1 (HIV-1) infection is a global priority. We tested the efficacy of a DNA prime-recombinant adenovirus type 5 boost (DNA/rAd5) vaccine regimen in persons at increased risk for HIV-1 infection in the United States. METHODS At 21 sites, we randomly assigned 2504 men or transgender women who have sex ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید